Salesforce shares rise as investors refocus on Agentforce traction after FY26 results

Salesforce (CRM) is up 4.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks like a relief rally following last week’s FY26 Q4/full-year update, as investors refocus on Salesforce’s AI-agent (Agentforce) traction and recurring-revenue durability. Recent company updates pointing to early enterprise adoption and expanding use cases for Agentforce likely helped sentiment after a choppy post-earnings tape.

Details:

Salesforce posted fourth-quarter and full fiscal-year 2026 results on February 25, 2026, highlighting momentum tied to its “Agentic Enterprise” positioning and increased emphasis on AI agents.

Management commentary in the FY26 results emphasized Agentforce as a key product driver, which may have supported a rebound in expectations for AI-related growth over the next few quarters.

On February 26, 2026, Salesforce said more than 180 organizations had selected Agentforce IT Service within about four months of general availability, suggesting faster-than-typical early adoption for a new platform module.

This could also be amplified by investors rotating back into large-cap software names after recent pullbacks, with CRM benefiting from perceived valuation support.

Sources:

Salesforce Investor Relations, Salesforce Newsroom, Morningstar

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRM Insider Trading Activity

$CRM insiders have traded $CRM stock on the open market 261 times in the past 6 months. Of those trades, 3 have been purchases and 258 have been sales.

Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:

PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 5 sales selling 134,662 shares for an estimated $31,605,031.
G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
MARC BENIOFF (Chair and CEO) has made 0 purchases and 252 sales selling 94,622 shares for an estimated $23,346,543.
DAVID BLAIR KIRK has made 2 purchases buying 5,336 shares for an estimated $1,366,549 and 0 sales.
NEELIE KROES sold 3,893 shares for an estimated $929,275

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRM Hedge Fund Activity

We have seen 1,298 institutional investors add shares of $CRM stock to their portfolio, and 1,672 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP added 47,189,352 shares (+24056.7%) to their portfolio in Q4 2025, for an estimated $12,500,931,238
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 25,418,477 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $6,733,608,742
SANDERS CAPITAL, LLC added 8,615,819 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,282,416,611
JPMORGAN CHASE & CO removed 6,496,920 shares (-49.8%) from their portfolio in Q4 2025, for an estimated $1,721,099,077
AMERIPRISE FINANCIAL INC added 3,930,311 shares (+80.5%) to their portfolio in Q4 2025, for an estimated $1,041,178,687
CARDANO RISK MANAGEMENT B.V. added 3,504,605 shares (+924.7%) to their portfolio in Q4 2025, for an estimated $928,404,910
HARRIS ASSOCIATES L P added 2,744,748 shares (+39.0%) to their portfolio in Q4 2025, for an estimated $727,111,192

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRM Congressional Stock Trading

Members of Congress have traded $CRM stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:

REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/09, 01/29 and 0 sales.
SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.
REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 12/16.
SENATOR JOHN BOOZMAN sold up to $15,000 on 11/13.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CRM Analyst Ratings

Wall Street analysts have issued reports on $CRM in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 02/26/2026
BTIG issued a "Buy" rating on 12/17/2025
Citizens issued a "Market Outperform" rating on 12/04/2025
Baird issued a "Outperform" rating on 12/04/2025
Wedbush issued a "Outperform" rating on 12/04/2025
BMO Capital issued a "Outperform" rating on 12/04/2025
Needham issued a "Buy" rating on 12/04/2025

To track analyst ratings and price targets for $CRM, check out Quiver Quantitative's $CRM forecast page.

$CRM Price Targets

Multiple analysts have issued price targets for $CRM recently. We have seen 34 analysts offer price targets for $CRM in the last 6 months, with a median target of $266.0.

Here are some recent targets:

Tyler Radke from Citigroup set a target price of $200.0 on 03/02/2026
Gil Luria from DA Davidson set a target price of $200.0 on 02/27/2026
Gregg Moskowitz from Mizuho set a target price of $265.0 on 02/26/2026
Billy Fitzsimmons from Piper Sandler set a target price of $250.0 on 02/26/2026
Allan Verkhovski from BTIG set a target price of $255.0 on 02/26/2026
Scott Berg from Needham set a target price of $400.0 on 02/26/2026
Rishi Jaluria from RBC Capital set a target price of $210.0 on 02/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.